Intranasal Dexmedetomidine Versus Esketamine As Premedication for the Sedation of Pediatric Patients: A Systematic Review and Meta-Analysis
Cureus · 13.05.2026
DOI: 10.7759/cureus.108763 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 13.05.2026. Verfasst von Lelian Ghaly und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neonatology, Queens Hospital Center, London, GBR. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Preoperative anxiety is a common problem in pediatric surgical patients and is a recognized predictor of emergence delirium (ED) and postoperative negative behavioral changes (PNBC). Intranasal premedication has emerged as a preferred route in children. Both dexmedetomidine and esketamine have demonstrated independent efficacy in this context. Their pharmacological complementarity has prompted growing interest in their combined use, yet no systematic review has comprehensively compared their efficacy and safety as monotherapies across pediatric procedural settings. This review aimed to evaluate and compare intranasal dexmedetomidine versus intranasal esketamine in pediatric patients. The study was conducted in accordance with the Cochrane Handbook and reported following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Five electronic databases were searched without date restriction. Risk of bias was assessed using the Cochrane RoB 2 tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Scale for the cohort study. Pooled risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals were calculated using RevMan 5.4, with fixed- or random-effects models applied based on heterogeneity. The final analysis included five studies (four RCTs, one prospective cohort) with a combined sample of 481 pediatric participants. In elective surgical settings, dexmedetomidine at 2 µg/kg significantly reduced ED incidence compared to esketamine (RR 0.57 (0.38, 0.86); p=0.008) and was associated with significantly lower Pediatric Anesthesia Emergence Delirium (PAED) scale scores (MD -1.28 (-2.36, -0.20); p=0.02). Conversely, esketamine demonstrated significantly lower PAED scores in the bronchoscopy subgroup (MD 2.73 (1.84, 3.62); p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neonatology, Queens Hospital Center, London, GBR.
- Pediatrics, Northampton General Hospital, Northampton, GBR.
- Plastic Surgery, Minia University Hospital, Minia, EGY.
- Surgical Oncology, Nasser Institute Hospital for Research and Treatment, Cairo, EGY.
- Pediatric Surgery, Minia University Hospital, Minia, EGY.
- Urology, Minia University Hospital, Minia, EGY.
Zitieren
APA
Ghaly, L., Al Nuaimi, A., Ragab, A., Gamal, M. O., Asida, M. M., Sayed, A., Alemam, M. M., Adel, M., & Hesham Gamal, M. (2026). Intranasal Dexmedetomidine Versus Esketamine As Premedication for the Sedation of Pediatric Patients: A Systematic Review and Meta-Analysis. Cureus. https://doi.org/10.7759/cureus.108763
Vancouver
Ghaly L, Al Nuaimi A, Ragab A, Gamal MO, Asida MM, Sayed A, et al. Intranasal Dexmedetomidine Versus Esketamine As Premedication for the Sedation of Pediatric Patients: A Systematic Review and Meta-Analysis. Cureus. 2026. doi:10.7759/cureus.108763
BibTeX
@article{Ghaly2026,
author = {Ghaly, Lelian and Al Nuaimi, Ayat and Ragab, Abdelrahman and Gamal, Mohamed O and Asida, Mahmoud M and Sayed, Abdelrahman and Alemam, Mohamad M and Adel, Manar and Hesham Gamal, Mohamed},
title = {Intranasal Dexmedetomidine Versus Esketamine As Premedication for the Sedation of Pediatric Patients: A Systematic Review and Meta-Analysis},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108763}
}
EUVIMED